Dr. Lorrie Kirshenbaum News Archive
Rady Faculty of Health Sciences
UM researchers identify protein linked to heart failure in chemo patients: Finding could save millions of lives
November 4, 2022 —
A team led by Dr. Lorrie Kirshenbaum from the Rady Faculty of Health Sciences and St. Boniface Hospital Research has identified a protein called TRAF2 that stops functioning in cancer patients taking the chemotherapy drug doxorubicin, which can result in heart failure.
Rady Faculty of Health Sciences
Canadian Cardiovascular Society honours Dr. Lorrie Kirshenbaum
October 26, 2020 —
A University of Manitoba Rady Faculty of Health Sciences professor/St Boniface Hospital Albrechtsen Research Centre researcher was awarded with the 2020 Canadian Cardiovascular Society Research Achievement Award.
Rady Faculty of Health Sciences
UM research team helps develop experimental drug to prevent cardiac damage in cancer patients
April 23, 2020 —
A collaborative study has found that an experimental drug may help prevent cardiac damage resulting from a drug used to treat many types of cancer.
Six new and renewed Canada Research Chairs
May 31, 2018 —
Four new CRCs have been awarded to U of M professors and another two have been renewed
Dr. Kirshenbaum named as director of the Institute of Cardiovascular Sciences
May 30, 2017 —
The University of Manitoba and St. Boniface Hospital announce the appointment of Dr. Lorrie Kirshenbaum as director of the Institute of Cardiovascular Sciences at St. Boniface Hospital Albrechtsen Research Centre
Heart cell protein study provides clue to cancer’s “Achilles’ heel”
September 28, 2015 —
'We are very excited and optimistic this discovery'